NEXGEL, Inc. (NXGLW) community

NXGLWNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as NXGL

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026Score 6/3072% below fair value

$0.01+0.00 (0.00%)

Close on Oct 30, 2026Market cap $34.21MP/E –Yield –

Community

Notes and questions about Nexgel from other investors

No posts about NXGLW yet

Discussion is coming to every stock. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Where these numbers come from

Parsed from the XBRL in Nexgel's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-20 reverse split on Oct 12, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is NXGLW.

Compare: NXGLW vs SNOA · NXGLW vs NEPH · NXGLW vs SRTS · NXGLW vs MDNC · NXGLW vs NSPR

Revenue growth3.4% · median 24.2%

Gross margin35.1% · median 38.9%

Operating margin-44.8% · median -6.4%

Net margin-51.3% · median -10.3%

Company	Revenue	Growth
SNOA	$21.92M	+47.0%
NEPH	$20.72M	+24.2%
SRTS	$17.51M	-53.4%
NXGLW	$12.07M	+3.4%
NSPR	$10.84M	+53.4%
MDNC	$10.21M	-10.9%

Company

Next earnings (est.): Nov 11, 2026, before open
Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: December 31
Employees: 19
Auditor: Turner, Stone & Company, L.L.P.
SEC CIK: 1468929

Advertisement
300 × 250